Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 42% ± 15% | |
lung | 16 studies | 46% ± 17% | |
intestine | 11 studies | 44% ± 21% | |
brain | 11 studies | 34% ± 12% | |
eye | 10 studies | 41% ± 19% | |
kidney | 9 studies | 47% ± 12% | |
bone marrow | 6 studies | 36% ± 10% | |
liver | 6 studies | 40% ± 20% | |
pancreas | 4 studies | 47% ± 20% | |
placenta | 4 studies | 45% ± 25% | |
uterus | 4 studies | 47% ± 15% | |
prostate | 4 studies | 28% ± 10% | |
lymph node | 4 studies | 45% ± 6% | |
breast | 4 studies | 35% ± 11% | |
heart | 3 studies | 30% ± 10% | |
adrenal gland | 3 studies | 38% ± 2% | |
esophagus | 3 studies | 51% ± 26% | |
skin | 3 studies | 32% ± 10% | |
thymus | 3 studies | 64% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 26485.10 | 1445 / 1445 | 100% | 91.63 | 183 / 183 |
ovary | 100% | 18102.32 | 180 / 180 | 100% | 103.55 | 430 / 430 |
prostate | 100% | 17249.93 | 245 / 245 | 100% | 151.37 | 502 / 502 |
stomach | 100% | 28091.71 | 359 / 359 | 100% | 105.15 | 286 / 286 |
intestine | 100% | 29837.23 | 966 / 966 | 100% | 127.23 | 526 / 527 |
skin | 100% | 27056.07 | 1809 / 1809 | 100% | 173.37 | 471 / 472 |
uterus | 100% | 17172.44 | 170 / 170 | 100% | 138.37 | 458 / 459 |
kidney | 100% | 38229.93 | 89 / 89 | 100% | 160.82 | 899 / 901 |
breast | 100% | 20901.81 | 459 / 459 | 100% | 150.04 | 1115 / 1118 |
pancreas | 100% | 14719.84 | 327 / 328 | 100% | 90.48 | 178 / 178 |
thymus | 100% | 23266.11 | 652 / 653 | 100% | 156.08 | 604 / 605 |
adrenal gland | 100% | 39185.41 | 258 / 258 | 100% | 147.15 | 229 / 230 |
bladder | 100% | 21360.71 | 21 / 21 | 99% | 127.17 | 501 / 504 |
liver | 99% | 16952.39 | 224 / 226 | 100% | 114.87 | 405 / 406 |
brain | 99% | 24236.61 | 2607 / 2642 | 100% | 161.52 | 705 / 705 |
lung | 99% | 17035.25 | 571 / 578 | 100% | 115.20 | 1152 / 1155 |
adipose | 100% | 20645.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 177.48 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 220.98 | 29 / 29 |
muscle | 100% | 61367.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 20273.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 165.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.17 | 1 / 1 |
blood vessel | 100% | 19144.79 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 69932.15 | 842 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 15551.27 | 776 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0006754 | Biological process | ATP biosynthetic process |
GO_0045471 | Biological process | response to ethanol |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_0014850 | Biological process | response to muscle activity |
GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
GO_0006629 | Biological process | lipid metabolic process |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0045261 | Cellular component | proton-transporting ATP synthase complex, catalytic core F(1) |
GO_0005754 | Cellular component | mitochondrial proton-transporting ATP synthase, catalytic core |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0009986 | Cellular component | cell surface |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0045259 | Cellular component | proton-transporting ATP synthase complex |
GO_0043531 | Molecular function | ADP binding |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0002020 | Molecular function | protease binding |
GO_0042288 | Molecular function | MHC class I protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0043532 | Molecular function | angiostatin binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ATP5F1A |
Protein name | ATP synthase subunit alpha, mitochondrial ATP synthase F1 subunit alpha ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha) |
Synonyms | ATP5A ATPM ATP5AL2 ATP5A1 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Subunits alpha and beta form the catalytic core in F(1). Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits. Subunit alpha does not bear the catalytic high-affinity ATP-binding sites (By similarity). Binds the bacterial siderophore enterobactin and can promote mitochondrial accumulation of enterobactin-derived iron ions . . |
Accessions | K7EJP1 ENST00000586592.5 ENST00000593152.6 [P25705-2] K7ERX7 ENST00000591981.5 ENST00000398752.11 [P25705-1] ENST00000590406.5 ENST00000592364.5 ENST00000590324.5 K7ESA0 ENST00000585650.1 ENST00000590665.5 [P25705-3] K7EQU6 K7EM08 ENST00000589252.5 K7EKV9 K7EK77 P25705 ENST00000592989.1 ENST00000589869.5 K7EQH4 K7ENJ4 A0A0A0MTS3 ENST00000282050.6 [P25705-1] ENST00000590156.5 |